Compassionate use INDs are filed for each individual patient. With the current environment the FDA might be willing to forego that.

Something of interest, one of the conditions that must be satisfied for the approval of compassionate use - The FDA determines that there is sufficient evidence of the safety and effectiveness of the investigational product to support its use in the particular circumstance.